山本 哲哉 やまもと てつや 先生

来歴等

略歴

1989年 筑波大学医学専門学校 卒業
2002年 筑波大学大学院博士課程医学研究科 修了 医学博士取得
2004年 筑波大学大学院人間総合科学研究科脳神経外科 講師
2012年 Tübingen大学 Research Fellow
2015年 筑波大学医学医療系脳神経外科 准教授
2017年 横浜市立大学大学院医学研究科脳神経外科学 主任教授

論文

• 1. The Incision Edge "Lifting Method" in Cerebral Bypass Surgery: A novel optional technique for narrow or thin recipient arteries. World Neurosurg. 2020 Jun 16:S1878-8750(20)31335-8.

  Miyazaki R, Murata H, Sato M, Ueno R, Ikegaya N, Matsumoto S, Abe H, Nagao K, Shimizu N, Tateishi K, Suenaga J, Yamamoto T

• 2. Human recombinant erythropoietin improves motor function in rats with spinal cord compression-induced cervical myelopathy. PLoS One. 2019 Dec 10;14(12):e0214351.

  Tanaka T, Murata H, Miyazaki R, Yoshizumi T, Sato M, Ohtake M, Tateishi K, Kim P, Yamamoto T

• 3. Interhemispherically dynamic representation of an eye movement-related activity in mouse frontal cortex. Elife. 2019 Nov 5;8:e50855.

  Sato TR, Itokazu T, Osaki H, Ohtake M, Yamamoto T, Sohya K, Maki T, Sato TK

• 4. Is intracranial electroencephalography useful for planning resective surgery in intractable epilepsy with ulegyria? J Neurosurg. 2019 Oct 25:1-6.

  Takayama Y, Ikegaya N, Iijima K, Kimura Y, Muraoka N, Kaneko Y, Yamamoto T, Iwasaki M

• 5.Autocrine Production of PDGF Stimulated by the Tenascin-C-Derived Peptide TNIIIA2 Induces Hyper-Proliferation in Glioblastoma Cells.　Int J Mol Sci. 2019 Jun 28;20(13).

  Fujita M, Yamamoto T, Iyoda T, Fujisawa T, Nagai R, Kudo C, Sasada M, Kodama H, Fukai F.

• 6.Aggressive Progression in Glioblastoma Cells through Potentiated Activation of Integrin α5β1 by the Tenascin-C-Derived Peptide TNIIIA2.　Mol Cancer Ther. 2019 Jun 12.

  Fujita M, Yamamoto T, Iyoda T, Fujisawa T, Sasada M, Nagai R, Kudo C, Otsuka K, Kamiya S, Kodama H, Fukai F.　

• 7.Oxidative stress-responsive apoptosis inducing protein (ORAIP) plays a critical role in cerebral ischemia/reperfusion injury.　Sci Rep. 18;9:13512, 2019

  Kishimoto M, Suenaga J, Takase H, Araki K, Yao T, Fujimura T, Murayama K, Okumura K, Ueno R, Shimizu N, Kawahara N, Yamamoto T, Seko Y.　

• 8. Comparing retreatments and expenditures in flow diversion versus coiling for unruptured intracranial aneurysm treatment: a retrospective cohort study using a real-world national database. Neurosurgery 2019

  Fukuda H, Sato D, Kato Y, Tsuruta W, Katsumata M, Hosoo H, Matsumaru Y, Yamamoto T.

• 9.Aortic and Internal Carotid Atherosclerosis in Patients with Carotid Stenosis: Semiautomatic Volumetric Analysis of Low-Attenuation Plaque on Curved Planar Reformations Using MDCT Angiographic Data.　Biomed Res Int. 2019 Apr 22;2019:5817534.

  Manaka H, Torimoto I, Sekikawa Z, Kasama K, Yamamoto T, Takebayashi S.　

• 10.PI3K/AKT/mTOR Pathway Alterations Promote Malignant Progression and Xenograft Formation in Oligodendroglial Tumors.　Clin Cancer Res. 2019 Jul 15;25(14):4375-4387

  Tateishi K, Nakamura T, Juratli TA, Williams EA, Matsushita Y, Miyake S, Nishi M, Miller JJ, Tummala SS, Fink AL, Lelic N, Koerner MVA, Miyake Y, Sasame J, Fujimoto K, Tanaka T, Minamimoto R, Matsunaga S, Mukaihara S, Shuto T, Taguchi H, Udaka N, Murata H, Ryo A, Yamanaka S, Curry WT, Dias-Santagata D, Yamamoto T, Ichimura K, Batchelor TT, Chi AS, Iafrate AJ, Wakimoto H, Cahill DP.　

• 11.Molecular genetics and therapeutic targets of pediatric low-grade gliomas. Brain Tumor Pathol. 2019 Apr;36(2):74-83.

  Tateishi K, Nakamura T, Yamamoto T.　

• 12.Genome-wide DNA methylation profiling shows molecular heterogeneity of anaplastic pleomorphic xanthoastrocytoma.　Cancer Sci. 2019 Feb;110(2):828-832.

  Nakamura T, Fukuoka K, Nakano Y, Yamasaki K, Matsushita Y, Yamashita S, Ikeda J, Udaka N, Tanoshima R, Shiba N, Tateishi K, Yamanaka S, Yamamoto T, Hirato J, Ichimura K.　

• 13.Three-dimensional multimodality fusion imaging as an educational and planning tool for deep-seated meningiomas. Br J Neurosurg. 32:509-515, 2018

  Sato M, Tateishi K, Murata H, Kin T, Suenaga J, Takase H, Yoneyama T, Nishii T, Tateishi U, Yamamoto T, Saito N, Inoue T, Kawahara N.

• 14.Delayed C5 Palsy After Anterior Cervical Decompression Surgery: Preoperative Foraminal Stenosis and Postoperative Spinal Cord Shift Increase the Risk of Palsy. World Neurosurg. 2018 Dec;120:e1107-e1119.

  Takase H, Murata H, Sato M, Tanaka T, Miyazaki R, Yoshizumi T, Tateishi K, Kawahara N, Yamamoto T.

• 15. Concomitant administration of radiation with eribulin improves the survival of mice harboring intracerebral glioblastoma. Cancer Sci. 2018 Jul;109(7):2275-2285

  Miki S, Imamichi S, Fujimori H, Tomiyama A, Fujimoto K, Satomi K, Matsushita Y, Matsuzaki S, Takahashi M, Ishikawa E, Yamamoto T, Matsumura A, Mukasa A, Nishikawa R, Masutomi K, Narita Y, Masutani M, Ichimura K:

• 16.Alternating magnetic field enhances cytotoxicity of Compound C. Cancer Sci. 109:3483-3493, 2018.

  Akimoto T, Umemura M, Nagasako A, Ohtake M, Fujita T, Yokoyama U, Eguchi H, Yamamoto T, Ishikawa Y:

• 17. Safety and efficacy of preoperative embolization in patients with meningioma. Journal of Neurological Surgery. Part B, Skull Base. 79(Suppl 4):S328-S333, 2018.

  Manaka H, Sakata K, Tatezuki J, Shinohara T, Shimohigoshi W, Yamamoto T

• 18. SDHB-negative jugular foramen paraganglioma manifesting malignant progression with pseudo-hypoxia related atypical uptake of [18F]-FDG: A case report. World Neurosurgery. 114: 47-52, 2018.

  Ohtake M, Tateishi K, Murata H, Nagashima Y, Yamanaka S, Yamamoto T

• 19.Radiobiological response of U251MG, CHO-K1 and V79 cell lines to accelerator-based boron neutron capture therapy. Journal of Radiation Research. 59(2):101-107, 2018.

  Sato E, Zaboronok A, Yamamoto T, Nakai K, Taskaev S, Volkova O, Mechetina L, Taranin A, Kanygin V, Isobe T, Mathis BJ, Matsumura A

• 20.Spinal Cord Infarction in the Region of the Posterior Spinal Artery After Embolization for Vertebral Artery Dissection. Operative Neurosurgery (Hagerstown, Md.) 15:701-710, 2018

  Tsuruta W, Yamamoto T, Ikeda G, Sato M, Ito Y, Takigawa T, Marushima A, Nakai Y, Matsumaru Y, Matsumura A

• 21.Evaluation of the extent of resection and detection of ischemic lesion with intraoperative MRI in glioma surgery: Is intraoperative MRI superior to early postoperative MRI? , J Neurosurg 1:1-8, 2018

  Masuda Y, Akutsu H, Ishikawa E, Matsuda M, Masumoto T, Hiyama T, Yamamoto T, Kohzuki H, Takano S, Matsumura A

• 22. Co-morbidity and quality of life in childhood cancer survivors treated with proton beam therapy. Pediatrics International. 59:1039-1045, 2017

  Fukushima H, Fukushima T, Suzuki R, Iwabuchi A, Hidaka K, Masumoto K, Muroi A, Yamamoto T, Mizumoto M, Sakurai H, Sumazaki R

• 23.A single institutional retrospective evaluation for younger patients with primary central nervous lymphomas on a modified R-MPV regimen followed by radiotherapy and high dose cytarabine. Journal of Clinical and Experimental Hematopathology. 57(2):41-46, 2017.

  Hattori K, Sakata-Yanagimoto M, Okoshi Y, Kato T, Kurita N, Yokoyama Y, Obara N, Takano S, Ishikawa E, Yamamoto T, Matsumura A, Hasegawa Y, Chiba S

• 24.MyD88 (L265P) mutation is associated with an unfavorable outcome of primary central nervous system lymphoma. British Journal of Haematology. 177(3): 492-494, 2017.

  Hattori K, Sakata-Yanagimoto M, Okoshi Y, Goshima Y, Yanagimoto S, Nakamoto-Matsubara R, Sato T, Noguchi M, Takano S, Ishikawa E, Yamamoto T, Matsumura A, Chiba S

• 25. A comparative study of dose distribution of PBT, 3D-CRT and IMRT for pediatric brain tumors. Radiation Oncology. 12(1):40, 2017.

  Takizawa D, Mizumoto M, Yamamoto T, Oshiro Y, Fukushima H, Fukushima T, Terunuma T, Okumura T, Tsuboi K, Sakurai H

• 26. Sodium Bicarbonate Facilitates Hemostasis in the Presence of Cerebrospinal Fluid Through Amplification of Platelet Aggregation. Neurosurgery 78(2):274-84, 2016.

  Kozuma Y, Yamamoto T, Ishikawa E, Yoshida F, Akutsu H, Matsuda M, Nakai K, Tsuruta W, Takano S, Matsumura A, Ninomiya H

• 27.Movable intraoperative magnetic resonance imaging incorporating a seismic system. Clinical Neurology and Neurosurgery. 135:57–61, 2015.

  Akutsu H, Yamamoto T, Masuda Y, Ishikawa E, Masumoto T, Matsuda M, Matsumura A

• 28.Proton beam therapy for pediatric ependymoma. Pediatrics International. 57(4):567-571, 2015.

  Mizumoto M, Oshiro Y, Takizawa D, Fukushima T, Fukushima H, Yamamoto T, Muroi A, Okumura T, Tsuboi K, Sakurai H

• 29.Photodynamic Diagnosis Using 5-Aminolevulinic Acid in 41 Biopsies for Primary Central Nervous System Lymphoma. Photochemistry and Photobiology, 91(6):1452-7, 2015.

  Yamamoto T, Ishikawa E, Miki S, Sakamoto N, Zaboronok A, Matsuda M, Akutsu H, Nakai K, Tsuruta W, Matsumura A

• 30. Rosette-forming glioneuronal tumor originating in the hypothalamus. Brain Tumor Pathology, 32(4):291-296, 2015

  Yamamoto T, Matsubara T, Satomi K, Sakamoto N, Matsuda M, Muroi A, Ishikawa E, Akutsu H, Nakai K, Matsumura A:

著書

• ＣＱ２上衣腫，ＣＱ３頭蓋咽頭腫，小児・ＡＹＡ世代の脳腫瘍に対する陽子線治療診療ガイドライン2019年版，公益社団法人　日本放射線腫瘍学会　一般社団法人　日本小児血液・がん学会編，金原出版株式会社，pp49-60，2019

• 小児がんの陽子線治療　小児固形がん患者のQOL向上を目指して，長嶋達也監修，編集室なるにあ，2018.4